Compare RMD & KDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | KDP |
|---|---|---|
| Founded | 1989 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 36.3B |
| IPO Year | 1995 | 1993 |
| Metric | RMD | KDP |
|---|---|---|
| Price | $245.15 | $28.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | ★ $289.09 | $35.11 |
| AVG Volume (30 Days) | 924.4K | ★ 14.8M |
| Earning Date | 01-29-2026 | 10-27-2025 |
| Dividend Yield | 0.98% | ★ 3.27% |
| EPS Growth | ★ 29.59 | N/A |
| EPS | ★ 9.77 | 1.16 |
| Revenue | $5,257,400,000.00 | ★ $16,174,000,000.00 |
| Revenue This Year | $9.85 | $8.12 |
| Revenue Next Year | $7.36 | $4.70 |
| P/E Ratio | $25.05 | ★ $24.27 |
| Revenue Growth | ★ 9.36 | 6.77 |
| 52 Week Low | $199.92 | $25.03 |
| 52 Week High | $293.81 | $36.12 |
| Indicator | RMD | KDP |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 48.65 |
| Support Level | $241.66 | $27.84 |
| Resistance Level | $247.45 | $28.38 |
| Average True Range (ATR) | 4.94 | 0.54 |
| MACD | -0.28 | -0.15 |
| Stochastic Oscillator | 18.66 | 14.58 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.